EARLY DRUG DISCOVERY

Brand Owner Address Description
ADVANCING EARLY DRUG DISCOVERY ICAGEN, INC. 4222 Emperor Blvd., Suite 350 Durham NC 27703 EARLY DRUG DISCOVERY;Pharmaceutical research and development services; drug discovery services, namely, assay optimization and miniaturization, method development, high throughput screening, high throughput confirmation and dose response, deconvolution of complex samples, synthetic chemistry, medicinal chemistry, compound logistics, purification, analytics and computational chemistry for early drug discovery research and development;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. A crystal comprising LuxP is obtained, and a binding site for autoinducer-2 (AI-2) identified. The X-ray crystallographic data for LuxP and a LuxP-AI-2 complex is determined and used in a drug discovery method. Pharmaceutical compositions comprising ligands identified by such drug discovery methods are used to treat bacterial infections.